Literature DB >> 24240822

Military trauma system in Afghanistan: lessons for civil systems?

Jeffrey A Bailey1, Jonathan J Morrison, Todd E Rasmussen.   

Abstract

PURPOSE OF REVIEW: This review focuses on development and maturation of the tactical evacuation and en route care capabilities of the military trauma system in Afghanistan and discusses hard-learned lessons that may have enduring relevance to civilian trauma systems. RECENT
FINDINGS: Implementation of an evidence-based, data-driven performance improvement programme in the tactical evacuation and en route care elements of the military trauma system in Afghanistan has delivered measured improvements in casualty care outcomes.
SUMMARY: Transfer of the lessons learned in the military trauma system operating in Afghanistan to civilian trauma systems with a comparable burden of prolonged evacuation times may be realized in improved patient outcomes in these systems.

Entities:  

Mesh:

Year:  2013        PMID: 24240822     DOI: 10.1097/MCC.0000000000000037

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  4 in total

1.  Forward surgical care: Emerging issues and challenges.

Authors:  Bipin Puri
Journal:  Med J Armed Forces India       Date:  2017-11-15

Review 2.  Prehospital Blood Product Resuscitation for Trauma: A Systematic Review.

Authors:  Iain M Smith; Robert H James; Janine Dretzke; Mark J Midwinter
Journal:  Shock       Date:  2016-07       Impact factor: 3.454

3.  Mortality of civilian patients with suspected traumatic haemorrhage receiving pre-hospital transfusion of packed red blood cells compared to pre-hospital crystalloid.

Authors:  J E Griggs; J Jeyanathan; M Joy; M Q Russell; N Durge; D Bootland; S Dunn; E D Sausmarez; G Wareham; A Weaver; R M Lyon
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-11-20       Impact factor: 2.953

4.  Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.

Authors:  Nicholas Crombie; Heidi A Doughty; Jonathan R B Bishop; Amisha Desai; Emily F Dixon; James M Hancox; Mike J Herbert; Caroline Leech; Simon J Lewis; Mark R Nash; David N Naumann; Gemma Slinn; Hazel Smith; Iain M Smith; Rebekah K Wale; Alastair Wilson; Natalie Ives; Gavin D Perkins
Journal:  Lancet Haematol       Date:  2022-03-07       Impact factor: 18.959

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.